Reviewing ENDRA Life Sciences Inc. (NDRA)’s and Integra LifeSciences Holdings Corporation (NASDAQ:IART)’s results

This is a contrast between ENDRA Life Sciences Inc. (NASDAQ:NDRA) and Integra LifeSciences Holdings Corporation (NASDAQ:IART) based on their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. The two companies are Medical Instruments & Supplies and they also compete with each other.

Valuation & Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ENDRA Life Sciences Inc. N/A 1333.61 9.73M -2.48 0.00
Integra LifeSciences Holdings Corporation 1.47B 3.24 60.80M 0.72 77.93

Table 1 showcases the gross revenue, earnings per share (EPS) and valuation of ENDRA Life Sciences Inc. and Integra LifeSciences Holdings Corporation.

Profitability

Table 2 has ENDRA Life Sciences Inc. and Integra LifeSciences Holdings Corporation’s return on equity, return on assets and net margins.

Net Margins Return on Equity Return on Assets
ENDRA Life Sciences Inc. 0.00% -405.7% -274.9%
Integra LifeSciences Holdings Corporation 4.14% 6% 2.2%

Liquidity

The Current Ratio and a Quick Ratio of ENDRA Life Sciences Inc. are 0.6 and 0.6. Competitively, Integra LifeSciences Holdings Corporation has 3.2 and 2.1 for Current and Quick Ratio. Integra LifeSciences Holdings Corporation’s better ability to pay short and long-term obligations than ENDRA Life Sciences Inc.

Analyst Recommendations

The Ratings and Recommendations for ENDRA Life Sciences Inc. and Integra LifeSciences Holdings Corporation are featured in the next table.

Sell Ratings Hold Ratings Buy Ratings Rating Score
ENDRA Life Sciences Inc. 0 0 0 0.00
Integra LifeSciences Holdings Corporation 0 6 5 2.45

Meanwhile, Integra LifeSciences Holdings Corporation’s consensus target price is $58.82, while its potential upside is 5.02%.

Institutional & Insider Ownership

The shares of both ENDRA Life Sciences Inc. and Integra LifeSciences Holdings Corporation are owned by institutional investors at 20.8% and 85.2% respectively. Insiders held 3.2% of ENDRA Life Sciences Inc. shares. Comparatively, Integra LifeSciences Holdings Corporation has 0.8% of it’s share held by insiders.

Performance

Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
ENDRA Life Sciences Inc. -1.13% -16.67% -48.22% -31.03% -42.43% 16.67%
Integra LifeSciences Holdings Corporation 0.13% 18.31% 3.34% -5.48% 8.33% 24.24%

For the past year ENDRA Life Sciences Inc. has weaker performance than Integra LifeSciences Holdings Corporation

Summary

Integra LifeSciences Holdings Corporation beats on 10 of the 11 factors ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc. develops photo- and thermo-acoustic medical technologies that bring new capabilities to existing ultrasound systems. Its photo-acoustic solutions help global medical researchers to screen and modify disease models with high image quality and volume scanning speed. The company offers the Nexus-128 system, a fully 3D imaging solution for imaging anatomy, physiology, and labeled molecular targets for institutions. Its thermo-acoustic technology is being developed to enable clinicians to use their existing ultrasound equipment to visualize tissue function, composition, and monitor various therapeutic interventions at the point of care. The company was incorporated in 2007 and is headquartered in Ann Arbor, Michigan.

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates through two segments, Specialty Surgical Solutions; and Orthopedics and Tissue Technologies. It offers neurosurgery and critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. The company also sells approximately 60,000 instrument patterns, and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. In addition, it provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, the company sells hardware products, such as bone and joint fixation, and joint replacement devices; implants; and instruments, which provide for the orthopedic reconstruction of bone in the hand, wrist, elbow, and shoulder, as well as the foot, ankle, and leg below the knee in the extremity bone and joint reconstruction procedures. It offers its products directly through various sales forces and other distribution channels in the United States, Europe, and internationally. Integra LifeSciences Holdings Corporation was founded in 1989 and is headquartered in Plainsboro, New Jersey.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.